Last reviewed · How we verify
NCT05216523: BARCOV
"Barotrauma in Admitted Covid-19 Cases - A Single Center Retrospective Study"
trial in Barotrauma in 251 participants. Completed in 30 November 2021.
30 November 2021
Quick facts
| Lead sponsor | Sultan Qaboos University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 251 |
| Start date | 24 June 2021 |
| Primary completion | 30 November 2021 |
| Estimated completion | 30 November 2021 |
| Sites | 1 location across Oman |
Conditions studied
- Barotrauma — all drugs for Barotrauma →
- COVID-19 — all drugs for COVID-19 →
Sponsor
Sultan Qaboos University
Who can join
Adults 18 to 89, any sex, with Barotrauma or COVID-19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A retrospective study is planned to find out the incidence and association type of respiratory support with barotrauma in Covid-19 cases admitted in Sultan Qaboos University Hospital. As widely known, Covid-19 affects the respiratory system primarily and is the main cause of admission to hospital. Depending upon the severity, different levels of respiratory support are offered to the patients. Normally patients with viral/bacterial respiratory diseases have a low incidence of barotrauma. Since this disease is new and it has been observed that a significant number of covid-19 patients develop barotrauma, hence it is deemed worthwhile to investigate the matter. All the patients admitted to the ward, high dependency unit, and intensive care unit will be scanned and those who developed barotrauma (pneumothorax, surgical emphysema, pneumo-pericardium, and pneumo-mediastinum) will be studied in detail and analyzed. This review is expected to highlight the problem and etiology and we might be able to suggest a management strategy to deal with this problem.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05216523
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Barotrauma
Currently open trials in the same condition.
- NCT05816954 — Imaging Biomarkers to Stratify the Risk of Barotrauma in ARDS · recruiting
Other Sultan Qaboos University trials
Trials by the same sponsor.
- NCT07474077 — Investigating the Efficacy of Tranexamic Acid as a Prophylactic Agent in Reducing Postpartum Hemorrhage Among Patients U · Phase 3 · not yet recruiting
- NCT07320248 — Virtual Reality for Patient Preparation Before Cardiac Catheterization in Oman · NA · not yet recruiting
- NCT07427134 — Pediatric Insulin Plan Calculator for T1DM Management · NA · not yet recruiting
- NCT06951451 — Effect of Smartphone Application (MED-AD) on Medication Adherence Among Patients With Cardiovascular Disease in Oman · NA · not yet recruiting
- NCT07460570 — Nurse-Led Culturally Adapted Palliative and End-of-Life Training for Oncology Nurses in Oman · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05216523 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sultan Qaboos University
- Last refreshed: 10 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05216523.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing